Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs
Quality of Care: The Impact of Multidisciplinary Care on Processes and Outcomes of Cancer Care
Quality of Care: The Impact of Multidisciplinary Care on Processes and Outcomes of Cancer Care
Sponsor study identifier
Secondary identifiers
observational
1,079
1 country
1
Study Start
April 16, 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
October 5, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Background:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 5, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 16, 2011
Date type not reportedThis date has not been verified as actual or estimated.
April 29, 2011
Actual (reported)May 2, 2011
Actual (reported)October 5, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg. 2010 Jul;38(1):1-5. doi: 10.1016/j.ejcts.2010.01.051. Epub 2010 Mar 4.
Fennell ML, Das IP, Clauser S, Petrelli N, Salner A. The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr. 2010;2010(40):72-80. doi: 10.1093/jncimonographs/lgq010.
Kathleen Castro, R.N.
National Cancer Institute (NCI)
1,079 participants (actual enrollment reported by the registry).
First Submitted
April 29, 2011
First Posted
May 2, 2011
Study Start
April 16, 2011
Date type not reportedThis date has not been verified as actual or estimated.
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)
Sidhom MA, Poulsen MG. Multidisciplinary care in oncology: medicolegal implications of group decisions. Lancet Oncol. 2006 Nov;7(11):951-4. doi: 10.1016/S1470-2045(06)70942-1.
Study Completion
October 5, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
December 17, 2019
Record last verified: 2015-10-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: